High materiality7/10
Nurix Therapeutics price target raised to $36 from $33 at Baird
Why it may matterVerify against the original reporting
Upside implied; price target well above current price.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Nurix Therapeutics price target raised to $36 from $33 at Baird.
- Baird raises NRIX target to $36 from $33.
Key facts
- 01
Target: $36
- 02
Posted price: $22.16
- 03
Analyst firm: Robert W. Baird
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.